
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+11
T-knife Therapeutics is a biopharmaceutical company dedicated to developing novel therapeutics to fight cancer, initially focused on T cell receptor (TCR) engineered T cell therapies (TCR-Ts), a modality that holds the potential to generate transformative responses in patients with solid tumors. The Companys unique approach leverages its proprietary HuTCR mouse platform, a next-generation T cell receptor and epitope discovery engine that produces fully human, tumor-specific TCRs, naturally selected in vivo for optimal affinity and high specificity. T-knife is advancing a portfolio of TCR-T product candidates against targets with high unmet medical need, including cancer testis antigens, oncoviral antigens and commonly...
Immunoncology,tumor immunology,t cell receptor,adoptive t cell therapy,cell therapy,gene therapy,tcr gene transfer,tcr generation,tcr characterization,cancer testis antigens,tumor antigens,target selection,retroviral vectors,neoepitopes,neoantigens,and gene therapy
T-knife therapeutics operates in the Biotechnology research industry.
T-knife therapeutics's revenue is 11m - 100m
T-knife therapeutics has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.